tiprankstipranks
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market
DMP
Dermapharm Holding SE
RESEARCH TOOLSreports
Want to see DE:DMP full AI Analyst Report?

Dermapharm Holding SE (DMP) Ratios

13 Followers

Dermapharm Holding SE Ratios

DE:DMP's free cash flow for Q4 2025 was €0.34. For the 2025 fiscal year, DE:DMP's free cash flow was decreased by € and operating cash flow was €0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.05 2.05 1.82 1.60 2.45
Quick Ratio
 1.09 1.09 0.78 0.79 1.30
Cash Ratio
 0.59 0.59 0.37 0.40 0.69
Solvency Ratio
 0.15 0.15 0.14 0.10 0.27
Operating Cash Flow Ratio
 0.60 0.53 0.62 0.56 1.32
Short-Term Operating Cash Flow Coverage
 1.60 1.40 2.37 1.97 154.38
Net Current Asset Value
€ -800.07M€ -800.07M€ -878.23M€ -985.13M€ -346.40M
Leverage Ratios
Debt-to-Assets Ratio
 0.48 0.48 0.47 0.50 0.37
Debt-to-Equity Ratio
 1.52 1.52 1.62 2.00 0.97
Debt-to-Capital Ratio
 0.60 0.60 0.62 0.67 0.49
Long-Term Debt-to-Capital Ratio
 0.57 0.57 0.59 0.64 0.49
Financial Leverage Ratio
 3.18 3.18 3.44 4.01 2.66
Debt Service Coverage Ratio
 1.50 1.44 1.82 1.29 15.64
Interest Coverage Ratio
 4.23 4.21 3.71 3.07 17.57
Debt to Market Cap
 0.41 0.49 0.46 0.47 0.25
Interest Debt Per Share
 20.52 20.52 19.28 21.17 9.85
Net Debt to EBITDA
 2.62 2.70 2.67 3.47 1.11
Profitability Margins
Gross Profit Margin
50.64%33.62%64.96%63.34%64.49%
EBIT Margin
19.90%19.03%19.51%14.18%22.31%
EBITDA Margin
27.84%26.98%27.18%23.39%32.18%
Operating Profit Margin
19.13%19.03%18.37%16.11%23.78%
Pretax Profit Margin
15.75%15.75%14.57%9.34%21.11%
Net Profit Margin
11.37%11.37%9.64%5.49%13.10%
Continuous Operations Profit Margin
11.27%11.28%9.46%5.33%14.26%
Net Income Per EBT
72.16%72.16%66.15%58.84%62.06%
EBT Per EBIT
82.34%82.76%79.29%57.95%88.76%
Return on Assets (ROA)
6.01%6.01%5.47%2.89%9.50%
Return on Equity (ROE)
20.45%19.07%18.83%11.57%25.25%
Return on Capital Employed (ROCE)
11.97%11.91%12.37%10.36%20.39%
Return on Invested Capital (ROIC)
8.01%7.97%7.65%5.55%12.45%
Return on Tangible Assets
11.64%11.64%11.48%6.01%16.05%
Earnings Yield
5.31%6.25%5.43%2.74%6.65%
Efficiency Ratios
Receivables Turnover
 9.60 9.60 11.24 11.90 10.23
Payables Turnover
 5.97 8.03 4.36 4.80 6.49
Inventory Turnover
 1.75 2.35 1.22 1.30 1.45
Fixed Asset Turnover
 3.66 3.66 3.75 3.43 4.54
Asset Turnover
 0.53 0.53 0.57 0.53 0.73
Working Capital Turnover Ratio
 3.28 3.72 4.70 4.11 3.02
Cash Conversion Cycle
 185.58 147.75 248.68 235.99 231.96
Days of Sales Outstanding
 38.03 38.03 32.46 30.67 35.67
Days of Inventory Outstanding
 208.65 155.16 299.85 281.31 252.55
Days of Payables Outstanding
 61.10 45.44 83.63 75.98 56.26
Operating Cycle
 246.68 193.19 332.31 311.98 288.22
Cash Flow Ratios
Operating Cash Flow Per Share
 3.84 3.37 3.74 4.08 5.36
Free Cash Flow Per Share
 3.06 2.59 3.03 3.30 4.63
CapEx Per Share
 0.78 0.78 0.71 0.77 0.72
Free Cash Flow to Operating Cash Flow
 0.80 0.77 0.81 0.81 0.86
Dividend Paid and CapEx Coverage Ratio
 2.28 2.00 2.35 2.24 1.85
Capital Expenditure Coverage Ratio
 4.91 4.31 5.27 5.28 7.40
Operating Cash Flow Coverage Ratio
 0.20 0.17 0.21 0.20 0.56
Operating Cash Flow to Sales Ratio
 0.18 0.16 0.17 0.19 0.28
Free Cash Flow Yield
6.61%6.58%7.79%7.80%12.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 18.85 16.00 18.41 36.55 15.05
Price-to-Sales (P/S) Ratio
 2.14 1.82 1.77 2.01 1.97
Price-to-Book (P/B) Ratio
 3.59 3.05 3.47 4.23 3.80
Price-to-Free Cash Flow (P/FCF) Ratio
 15.14 15.20 12.84 12.82 8.10
Price-to-Operating Cash Flow Ratio
 12.06 11.67 10.40 10.39 7.00
Price-to-Earnings Growth (PEG) Ratio
 1.10 0.96 0.22 -0.68 -0.42
Price-to-Fair Value
 3.59 3.05 3.47 4.23 3.80
Enterprise Value Multiple
 10.31 9.44 9.20 12.06 7.24
Enterprise Value
 3.34B 2.97B 2.95B 3.20B 2.39B
EV to EBITDA
 10.31 9.44 9.20 12.06 7.24
EV to Sales
 2.87 2.55 2.50 2.82 2.33
EV to Free Cash Flow
 20.29 21.29 18.10 18.00 9.56
EV to Operating Cash Flow
 16.16 16.35 14.66 14.59 8.27
Tangible Book Value Per Share
 -6.79 -6.79 -8.92 -10.74 -0.81
Shareholders’ Equity Per Share
 12.90 12.90 11.23 10.01 9.87
Tax and Other Ratios
Effective Tax Rate
 0.28 0.28 0.35 0.43 0.39
Revenue Per Share
 21.64 21.64 21.93 21.09 19.03
Net Income Per Share
 2.46 2.46 2.11 1.16 2.49
Tax Burden
 0.72 0.72 0.66 0.59 0.62
Interest Burden
 0.79 0.83 0.75 0.66 0.95
Research & Development to Revenue
 0.00 <0.01 <0.01 <0.01 0.01
SG&A to Revenue
 0.13 0.14 0.07 0.02 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.29 1.37 1.17 3.52 1.33
Currency in EUR